• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Vaccines / HPV / Is the Cervical Cancer Vaccine Good to Go?

Is the Cervical Cancer Vaccine Good to Go?

January 22, 2011 By Norma Leave a Comment

By:  Paula Byrne, Dr. Darina O’Flanagan and Dr. Brenda Corcoran

31 August 2010 – The Irish Times

VACCINE DEBATE: The arguments for and against the cervical cancer vaccination programme

NO 

Gardasil has never been proven to prevent cervical cancer, hasn’t been sufficiently tested on the target age group, and not enough is known about adverse reactions, writes PAULA BYRNE 

MOST PARENTS will do anything to protect their children. The idea that I could protect my little girl from cancer down the road is pretty compelling. This is the scenario with which we are presented by the makers of Gardasil, the vaccine purported to prevent cervical cancer.

However, the reality of this vaccine is far from straightforward.

Cervical cancer is relatively rare, with approximately 3.9 deaths per 100,000 people each year in Ireland. There is no epidemic to warrant the urgent introduction of this vaccine.

Cervical screening (pap screening) has been a public-health success. Deaths from the disease reduced by 70-80 per cent from 40 years ago due to more of these cancers being caught early. Most deaths nowadays are in women who did not get pap smears. So surely more investment in the screening programme is better use of public funds.

There are, as the old saying goes, lies, damned lies and statistics, and one would need to carefully study the clinical trials to understand how this vaccine is being framed as something that prevents cervical cancer when the reality is quite different.

YES 

The vaccine has been fully tested and will protect women from the most common forms of HPV-related cancer – and it is free, write DR DARINA O’FLANAGAN and DR BRENDA CORCORAN 

EACH YEAR in Ireland about 250 women are diagnosed with cervical cancer, and 80 die from it. At least 70 of these cases are linked to Human Papilloma Virus (HPV).

We now have a new vaccine to protect women from the most common forms of HPV-related cancer. From September, the HSE will offer a safe, fully tested HPV vaccine called Gardasil to every girl in the country who is starting first and second year in secondary school. It will then be offered to all future first years.

The vaccine is free, and international studies have shown that vaccinated women are less likely to become infected with HPV, and are therefore less likely to develop cervical cancer. Australia has already seen a reduction in genital warts, a key indicator of HPV, since vaccine was introduced.

The HSE programme, which will be mostly school-based, aims to achieve a high uptake of more than 80 per cent for the vaccine. Each girl will need three doses of the vaccine over a six-month period, which will substantially reduce their risk of developing cervical cancer as adults.

Read the rest of both arguments, for and against, here.

Related

Filed Under: HPV, Ireland, World News Tagged With: pap screening

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Follow-up to Gardasil: The Decision We Will Always Regret

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

the greater good movie trailer

The Greater Good Movie Trailer from BNP Pictures

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2025 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in